RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsReiterationPrice TargetHot
RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.
RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.